Envoy Medical Inc.

COCH | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.72

+$0.01 (+1.34%)

Sep 22, 2026, 10:51 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	207K	234K	241K	208K	222K	212K	225K	278K	302K	297K	316K	241K	218K	214K	237K	217K	160K	101K	n/a	n/a	n/a	n/a
Cost of Revenue	1.01M	961K	874K	820K	804K	815K	742K	819K	821K	738K	760K	677K	594K	650K	688K	537K	431K	213K	n/a	n/a	n/a	n/a
Gross Profit	-798K	-727K	-633K	-612K	-582K	-603K	-517K	-541K	-519K	-441K	-444K	-436K	-376K	-436K	-451K	-320K	-271K	-112K	n/a	n/a	n/a	n/a
Operating Income	-23.62M	-23.12M	-22.27M	-20.41M	-19.68M	-19.47M	-19.26M	-21.46M	-19.87M	-19.49M	-18.36M	-14.54M	-12.95M	-10.67M	-8.71M	-6.76M	-7.95M	-6.83M	-5.99M	-5.02M	-2.04M	-966.98K
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.47K	20.85K	28.69K	28.69K	23.22K	7.84K
Pretax Income	-23.4M	-23.11M	-23.76M	-21.79M	-21.27M	-19.52M	-20.8M	-21.07M	-13.55M	-22.85M	-29.83M	-36.41M	-39.32M	-27.31M	-15.92M	-9.17M	-2.26M	-652.3K	-251.74K	4.47M	-1.1M	-1.47M
Net Income	-23.4M	-23.11M	-23.76M	-21.79M	-21.27M	-19.52M	-20.8M	-21.07M	-13.55M	-22.85M	-29.83M	-36.41M	-39.32M	-27.31M	-15.92M	-9.17M	-2.26M	-652.3K	-251.74K	4.47M	-1.1M	-1.47M
Selling & General & Admin	8.8M	9.02M	9.15M	9.39M	8.63M	8.3M	8.56M	10.15M	9.49M	9.63M	8.93M	6.73M	6.12M	4.57M	3.47M	3.1M	5.28M	5.67M	5.99M	5.02M	2.04M	966.98K
Research & Development	14.03M	13.38M	12.49M	10.4M	10.46M	10.57M	10.18M	10.76M	9.86M	9.42M	8.99M	7.37M	6.46M	5.67M	4.79M	3.34M	2.41M	1.05M	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	22.82M	22.4M	21.64M	19.8M	19.09M	18.86M	18.74M	20.91M	19.35M	19.05M	17.92M	14.11M	12.58M	10.23M	8.26M	6.44M	7.68M	6.72M	5.99M	5.02M	2.04M	966.98K
Interest Expense	471K	1.1M	1.59M	1.97M	1.77M	1.28M	816K	432K	168K	36K	n/a	n/a	n/a	n/a	n/a	n/a	5.47K	5.47K	5.47K	5.47K	n/a	n/a
Selling & Marketing Expenses	846K	1.03M	1.22M	1.64M	1.63M	1.77M	1.73M	1.73M	1.73M	1.62M	1.67M	2.04M	1.64M	1.26M	885K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	23.83M	23.36M	22.51M	20.62M	19.9M	19.68M	19.48M	21.73M	20.17M	19.78M	18.68M	14.78M	13.17M	10.88M	8.94M	6.98M	8.11M	6.93M	5.99M	5.02M	2.04M	966.98K
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	104.04M	68.93M	46.1M	21.85M	21.38M	21.33M	21.33M	19.62M	19.6M	18.6M	19.6M	19.55M	19.55M	42.52M	53.13M	10.21M	53.13M	53.13M	53.13M	53.13M	53.13M	42M
Shares Outstanding (Diluted)	104.04M	68.93M	46.1M	21.85M	19.6M	21.33M	21.33M	19.62M	19.6M	18.6M	19.6M	19.55M	19.55M	42.52M	53.13M	11.22M	53.13M	53.13M	53.13M	53.13M	53.13M	42M
EPS (Basic)	-0.67	-0.92	-1.13	-1.32	-1.34	-1.29	-1.41	-1.30	-0.86	-1.27	-2.16	-2.13	-2.33	-1.82	-0.56	-0.43	-0.20	-0.02	-0.02	0.07	-0.03	-0.04
EPS (Diluted)	-0.67	-0.92	-1.13	-1.32	-1.34	-1.29	-1.41	-1.30	-0.86	-1.27	-2.16	-2.13	-2.32	-1.79	-0.53	-0.40	-0.18	-0.02	-0.02	0.07	-0.03	-0.04
EBITDA	-22.63M	-21.7M	-21.86M	-19.54M	-19.26M	-18.05M	-19.81M	-20.47M	-13.23M	-22.67M	-29.7M	-36.3M	-39.21M	-27.22M	-15.85M	-9.12M	6.33M	9.36M	9.75M	14.47M	342.01K	-1.47M
EBIT	-22.93M	-22.01M	-22.17M	-19.81M	-19.5M	-18.25M	-19.98M	-20.64M	-13.38M	-22.81M	-29.83M	-36.41M	-39.32M	-27.31M	-15.92M	-9.17M	-2.26M	-652.3K	-251.74K	4.47M	-1.1M	-1.47M
Depreciation & Amortization	303K	314K	302K	270K	243K	200K	173K	173K	153K	140K	133K	111K	104K	89K	75K	49K	8.59M	10.01M	10M	10M	1.44M	n/a